货号:A204285
同义名:
松果体素
/ N-Acetyl-5-methoxytryptamine; NSC 56423
Melatonin是一种由松果体分泌的激素,能调节睡眠周期,具有抗氧化、抗炎作用,同时是一种 ATF-6 抑制剂,能够下调 COX-2,增强线粒体自噬并调节凋亡和自噬的稳态。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Activating transcription factor 6 (ATF-6) is one of the three main endoplasmic reticulum(ER) transmembrane sensors that elicit the unfolded protein response(UPR). Melatonin (N-acetyl-5-methoxytryptamine), produced in the human pineal gland during the night phase of the light-dark cycle, plays important roles in physiological and pharmacological functions and also acts as a novel selective ATF-6 inhibitor. Melatonin treatment (10-5 mM) for 24 h after pretreatment by tunicamycin inhibited the expression COX-2 by downregulating ATF-6, which increased the apoptosis of HepG2 cells via CHOP and Bcl-2/Bax pathway[4]. Melatonin was an effective free radical scavenger and antioxidant which reduced amyloid β protein toxicity of Alzheimer’s disease, reduced oxidative damage in several models of Parkinson’s disease, protected against glutamate excitotoxicity, reduced ischemia-reperfusion injury, lowered neural damage due to d-aminolevulinic acid (phorphyria), hyperbaric hyperoxia and a variety of neural toxins. It also had been shown to reduce lipid peroxidation and oxidative damage to nuclear DNA[5]. |
| Concentration | Treated Time | Description | References | |
| Lithocarpus litseifolius leaf cells | 100 µM | 14 days | Increased accumulation of total flavonoids and dihydrochalcones (including Trilobatin) | Int J Mol Sci. 2024 Apr 23;25(9):4592 |
| NP cells | 1 mM | 24 h | Melatonin suppressed NLRP3 inflammasome activation and reduced IL-1β expression | Bone Res. 2020 Feb 18;8:10. |
| ARPE-19 cells | 2 mM | 24 h | Melatonin significantly reduced NaIO3-induced ARPE-19 cell death and inhibited apoptosis and mitochondrial dysfunction. | Cell Biosci. 2022 Aug 19;12(1):133. |
| Mouse oocytes | 10μM | 12 h | To determine whether supplementation of melatonin can ameliorate the quality of maternally aged oocytes in vitro by eliminating the excessive ROS. The results showed that melatonin treatment significantly reduced ROS levels, decreased DNA damage and apoptosis, and restored meiotic defects in aged oocytes. | Redox Biol. 2020 Jan;28:101327. |
| RT7 cells | 0, 100, 500, 1000 µM | 1 to 17 days | To investigate the effect of melatonin on the proliferation of RT7 cells, results showed that melatonin has a cytostatic effect on RT7 cells under normal conditions. | Cells. 2023 Aug 30;12(17):2178. |
| RT7 cells | 0, 100, 500, 1000 µM | 30 min | To investigate the effect of melatonin on the proliferation of RT7 cells after irradiation, results showed that cell proliferation was suppressed in a melatonin concentration-dependent manner. | Cells. 2023 Aug 30;12(17):2178. |
| Endothelial Progenitor Cells (EPCs) | 100 μM | 4 days | Under high glucose conditions, melatonin improved EPC survival, migration, and reduced senescence through AMPK, eNOS, and HO-1 pathways, reversing hyperglycemia-induced oxidative stress. | Int J Mol Sci. 2022 Aug 30;23(17):9839. |
| HCAECs | 0.5 mM | 6 h | Melatonin suppressed cell apoptosis and directly reduced the expression of endothelial cell damage markers in HCAECs. | Cell Prolif. 2022 Jun;55(6):e13251. |
| THP1 cell line | 0.5 mM | Melatonin decreased the production of pro-inflammatory cytokines in THP1 cell line. | Cell Prolif. 2022 Jun;55(6):e13251. | |
| SH-SY5Y human neuroblastoma cells | 100 nM | 24 h | To investigate the effect of melatonin on RA-induced gene expression, results showed that melatonin inhibited RA-induced expression of CYP26A1 and RARB genes. | Cells. 2023 Jan 11;12(2):286. |
| HaCaT cells | 1 nM | 6-8 h | To investigate the effect of melatonin on nNOS expression and NOx production in HaCaT cells. Results showed that 1 nM melatonin significantly increased nNOS mRNA and protein expression and enhanced NOx production within 6-8 h. | Int J Mol Sci. 2013 May 28;14(6):11259-76. |
| Lemna aequinoctialis | 10 µM | 28 days | Investigation of the effect of melatonin on the production of campesterol in Lemna aequinoctialis culture, showing the highest productivity of campesterol (1.79 mg/L). | BMC Plant Biol. 2022 Nov 25;22(1):545 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | NaIO3-induced retinal degeneration model | Oral | 25 or 50 mg/kg | Once daily for 7 days | Melatonin effectively reduced NaIO3-induced retinal injury and repaired the structure of retinal layers. | Cell Biosci. 2022 Aug 19;12(1):133. |
| ICR mice | NA/STZ-induced hyperglycemia model | Oral | 10, 20, 50 mg/kg | Once daily for 6 weeks | To investigate the effects of different doses of melatonin on glucose homeostasis, antioxidant ability, and adipokine secretion in NA/STZ-induced hyperglycemic mice. Results showed that melatonin could decrease oxidative stress, increase adiponectin levels, and improve dyslipidemia, especially in the high-dose group. | Nutrients. 2017 Oct 29;9(11):1187 |
| Mice | Aged mouse model | Intravenous injection | 100 mg/kg | Once daily for 10 days | To determine whether in vivo supplementation of melatonin can ameliorate the quality of aged oocytes by clearing the excessive ROS. The results showed that melatonin treatment significantly reduced ROS levels, decreased DNA damage and apoptosis, and restored meiotic defects in aged oocytes. | Redox Biol. 2020 Jan;28:101327. |
| ICR mice | Radiation-induced oral mucositis model | Intraperitoneal and drinking water | 100 mg/kg, 50 µg/mL | Single intraperitoneal injection, drinking water for 7 days | To investigate the preventive effect of melatonin on radiation-induced oral mucositis, results showed that melatonin significantly suppressed radiation-induced oral mucositis. | Cells. 2023 Aug 30;12(17):2178. |
| Mice | Streptozotocin (STZ)-induced diabetic mice | Intraperitoneal injection | 10 mg/kg | Daily for 4 weeks | Melatonin significantly improved blood flow recovery, EPC mobilization, and capillary density in ischemic hindlimbs of diabetic mice, reducing limb injury. | Int J Mol Sci. 2022 Aug 30;23(17):9839. |
| C57BL/6 mice | CAWS-induced KD mouse model | Intraperitoneal injection | 40 mg/kg | Once daily for 30 days | Melatonin alleviated vasculitis in the CAWS-induced KD mouse model. | Cell Prolif. 2022 Jun;55(6):e13251. |
| Rats | AF puncture-induced IVDD model | Intraperitoneal injection | 30 mg/kg | Weekly, until the day of euthanasia | Melatonin alleviated IVDD and LBP by inhibiting NLRP3 inflammasome activation and IL-1β expression | Bone Res. 2020 Feb 18;8:10. |
| Dose | Mice: 1 mg/kg - 50 mg/kg[4] (i.p.) |
| Administration | i.p. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00869128 | Diabetes Mellitus, Type 2 ... 展开 >> Insomnia 收起 << | Phase 2 | Completed | - | - |
| NCT00869128 | - | Completed | - | - | |
| NCT02500017 | Night-eating Syndrome | Not Applicable | Terminated(Difficulty recruiti... 展开 >>ng appropriate participants) 收起 << | - | United States, Connecticut ... 展开 >> Connecticut Mental Health Center New Haven, Connecticut, United States, 06519 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
4.31mL 0.86mL 0.43mL |
21.53mL 4.31mL 2.15mL |
43.05mL 8.61mL 4.31mL |
|
| CAS号 | 73-31-4 |
| 分子式 | C13H16N2O2 |
| 分子量 | 232.28 |
| SMILES Code | COC1=CC2=C(NC=C2CCNC(C)=O)C=C1 |
| MDL No. | MFCD00005655 |
| 别名 | 松果体素 ;N-Acetyl-5-methoxytryptamine; NSC 56423; 5-Methoxy-N-acetyltryptamine; Circadin; Melatonine; Regulin; NSC 113928 |
| 运输 | 蓝冰 |
| InChI Key | DRLFMBDRBRZALE-UHFFFAOYSA-N |
| Pubchem ID | 896 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 105 mg/mL(452.04 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 1 mg/mL(4.31 mM),配合低频超声助溶 无水乙醇: 12 mg/mL(51.66 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1